Chwilio Deddfwriaeth

Misuse of Drugs Act 1971

Status:

Point in time view as at 20/03/2024.

Changes to legislation:

There are currently no known outstanding effects for the Misuse of Drugs Act 1971, Part I. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Part IU.K. Class A Drugs

1U.K.The following substances and products, namely:—

[F1(a)]

  • Acetorphine.

  • [F2Alfentanil.]

  • Allylprodine.

  • Alphacetylmethadol.

  • Alphameprodine.

  • Alphamethadol.

  • Alphaprodine.

  • Anileridine.

  • Benzethidine.

  • Benzylmorphine (3-benzylmorphine).

  • Betacetylmethadol.

  • Betameprodine.

  • Betamethadol.

  • Betaprodine.

  • Bezitramide.

  • [F3Brorphine.]

  • Bufotenine.

  • [F4Butonitazene.]

  • F5...

  • F6...

  • [F7Carfentanil.]

  • Clonitazene.

  • Coca leaf.

  • Cocaine.

  • Desomorphine.

  • Dextromoramide.

  • Diamorphine.

  • Diampromide.

  • Diethylthiambutene.

  • [F8Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).]

  • DihydrocodeinoneO-carboxymethyloxime.

  • [F9Dihydroetorphine]

  • Dimenoxadole.

  • Dimepheptanol.

  • Dimethylthiambutene.

  • Dioxaphetyl butyrate.

  • Diphenoxylate.

  • Dipipanone.

  • [F10Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).]

  • Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.

  • [F11Ethyleneoxynitazene.]

  • Ethylmethylthiambutene.

  • [F2Eticyclidine.]

  • [F12Etodesnitazene (etazene).]

  • Etonitazene.

  • Etorphine.

  • Etoxeridine.

  • [F13Etryptamine]

  • Fentanyl.

  • [F14Flunitazene.]

  • [F15Fungus (of any kind) which contains psilocin or an ester of psilocin.]

  • Furethidine.

  • Hydrocodone.

  • Hydromorphinol.

  • Hydromorphone.

  • Hydroxypethidine.

  • Isomethadone.

  • [F16Isotonitazene.]

  • Ketobemidone.

  • Levomethorphan.

  • Levomoramide.

  • Levophenacylmorphan.

  • Levorphanol.

  • [F7Lofentanil]

  • Lysergamide.

  • Lysergide and otherN-alkyl derivatives of lysergamide.

  • Mescaline.

  • Metazocine.

  • Methadone.

  • Methadyl acetate.

  • [F17Methylamphetamine]

  • Methyldesorphine.

  • Methyldihydromorphine (6-methyldihydromorphine).

  • [F18Metodesnitazene (metazene).

  • Metonitazene.]

  • Metopon.

  • Morpheridine.

  • Morphine.

  • Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.

  • Myrophine.

  • F19...

  • Nicomorphine (3,6-dinicotinoylmorphine).

  • Noracymethadol.

  • Norlevorphanol.

  • Normethadone.

  • Normorphine.

  • Norpipanone.

  • Opium, whether raw, prepared or medicinal.

  • Oxycodone.

  • Oxymorphone.

  • Pethidine.

  • Phenadoxone.

  • Phenampromide.

  • Phenazocine.

  • [F20Phencyclidine.]

  • Phenomorphan.

  • Phenoperidine.

  • Piminodine.

  • Piritramide.

  • Poppy-straw and concentrate of poppy-straw.

  • Proheptazine.

  • Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).

  • [F21Protonitazene.]

  • Psilocin.

  • Racemethorphan.

  • Racemoramide.

  • Racemorphan.

  • [F22Remifentanil]

  • [F2Rolicyclidine.]

  • [F23Sufentanil.]

  • [F24Tapentadol.]

  • [F2Tenocylidine.]

  • Thebacon.

  • Thebaine.

  • [F23Tilidate.]

  • Trimeperidine.

  • [F25(6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52).]

  • [F264-Bromo-2,5-dimethoxy-a-methylphenethylamine].

  • 4-Cyano-2-dimethylamino-4,4-diphenylbutane.

  • 4-Cyano-1-methyl-4-phenyl-piperidine.

  • [F271-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).]

  • [F28N-Desethyl etonitazene.

  • N-Desethylisotonitazene.

  • N-Desethyl protonitazene.]

  • [F293,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921);]

  • [F303,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47,700).]

  • [F31(6aR,9R) R,9 R)- N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD);

  • (6aR,9R) R,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD);

  • (6aR,9R)R,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD).]

  • N,N-Diethyltryptamine.

  • [F322,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg]quinolin-9-yl}methanone (LSZ).]

  • N,N-Dimethyltryptamine.

  • 2,5-Dimethoxy-a,4-dimethylphenethylamine.

  • [F33N-Hydroxy-tenamphetamine.]

  • 1-Methyl-4-phenylpiperidine-4-carboxylic acid.

  • 2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.

  • [F344-Methyl-aminorex]

  • [F354-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR).]

  • 4-Phenylpiperidine-4-carboxylic acid ethyl ester.

  • [F36N-Piperidinyl-etonitazene (etonitazepipne).

  • N-Pyrrolidino-etonitazene (etonitazepyne).

  • N-Pyrrolidino protonitazene.]

[F37(b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say—

(i)by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;

(ii)by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;

(iii)by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;

(iv)by substitution at the 2-position of the tryptamine ring system with an alkyl substituent;]

[F38(ba)the following phenethylamine derivatives, namely:—

  • Allyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

  • 2-Amino-1-(3,4-dimethoxyphenyl)ethanol

  • Benzyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 4-Bromo-b,2,5-trimethoxyphenethylamine

  • N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

  • Cyclopropylmethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 2-(4,7-Dimethoxy-2,3-dihydro-1 H-indan-5-yl)ethylamine

  • 2-(4,7-Dimethoxy-2,3-dihydro-1 H-indan-5-yl)-1-methylethylamine

  • 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

  • 2-(1,4-Dimethoxy-2-naphthyl)ethylamine

  • 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

  • N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

  • 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

  • 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

  • a, a-Dimethyl-3,4-methylenedioxyphenethylamine

  • a, a-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

  • Dimethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

  • 4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine

  • 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

  • 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

  • 2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

  • 2-Methoxyethyl(a-methyl-3,4-methylenedioxyphenethyl)amine

  • 2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

  • b-Methoxy-3,4-methylenedioxyphenethylamine

  • 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

  • 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

  • 2-(a-Methyl-3,4-methylenedioxyphenethylamino)ethanol

  • a-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

  • N-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

  • O-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

  • a-Methyl-4-(methylthio)phenethylamine

  • b,3,4,5-Tetramethoxyphenethylamine

  • b,2,5-Trimethoxy-4-methylphenethylamine;]

[F39(c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N -alkylphenethylamine,a-methylphenethylamine, an N -alkyl-a-methylphenethylamine,a-ethylphenethylamine, or an N -alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents. ]

[F40(d)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i)by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii)by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii)by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv)by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v)by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi)by replacement of the N-propionyl group by another acyl group;

(e)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i)by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii)by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii)by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv)by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v)by formation of an N-oxide or of a quaternary base.]

[F41(f)any compound (not being benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from mescaline, 4-bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-dimethoxy-α,4-dimethylphenethylamine, N-hydroxytenamphetamine, or a compound specified in sub-paragraph (ba) or (c) above, by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.]

Textual Amendments

F1"(a)" inserted by S.I. 1977/1243, art. 3(a)

F2Word inserted by S.I. 1984/859, art. 2(2)

F3Word in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(a)

F4Word in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(b)

F7Word inserted by S.I. 1986/2230, art. 2(2)(a)

F8Word inserted by S.I. 1975/421, art. 3

F9Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003 /1243), art. 2(2)(a)

F10Word inserted by S.I. 1973/771, art. 2

F11Word in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(c)

F12Words in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(d)

F13Word in Sch. 2 Pt. I para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(2)

F14Word in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(e)

F15Words in Sch. 2 Pt. 1 para. 1 inserted (18.7.2005) by Drugs Act 2005 (c. 17), s. 21

F16Word in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(f)

F17Word in Sch. 2 Pt. 1 para. 1(a) inserted (18.1.2007) by The Misuse of Drugs Act 1971 (Amendment) Order 2006 (S.I. 2006/3331), art. 2(1)

F18Words in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(g)

F19Words repealed by S.I. 1973/771, art. 2

F20Word inserted by S.I. 1979/299, art. 2

F21Word in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(h)

F22Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003 /1243), art. 2(2)(b)

F23Word inserted by S.I. 1983/765, art. 2(a)

F24Word in Sch. 2 Pt. 1 para. 1(a) inserted (28.3.2011) by The Misuse of Drugs Act 1971 (Amendment) Order 2011 (S.I. 2011/744), arts. 1(1), 2

F26Words inserted by S.I. 1975/421, art. 3

F27Words in Sch. 2 Pt. 1 para. 1(a) inserted (11.3.2015) by The Misuse of Drugs Act 1971 (Amendment) Order 2015 (S.I. 2015/215), art. 3(a)

F28Words in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(i)

F30Words in Sch. 2 Pt. 1 para. 1(a) inserted (31.5.2017) by The Misuse of Drugs Act 1971 (Amendment) Order 2017 (S.I. 2017/634), art. 3

F35Words in Sch. 2 Pt. 1 para. 1(a) inserted (11.3.2015) by The Misuse of Drugs Act 1971 (Amendment) Order 2015 (S.I. 2015/215), art. 3(b)

F36Words in Sch. 2 Pt. 1 para. 1(a) inserted (20.3.2024) by The Misuse of Drugs Act 1971 (Amendment) Order 2024 (S.I. 2024/190), arts. 1(1), 2(2)(j)

F39Sch. 2 Pt. I para. 1(b)(c) added by S.I. 1977/1243, art. 3(b)

F40Sch. 2 Pt. I para. 1(d)(e) added by S.I. 1986/2230, art. 2(2)(b)

2U.K.Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.

3U.K.Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [F42not being a substance for the time being specified in Part II of this Schedule].

Textual Amendments

F42Words inserted by S.I. 1973/771, art. 2

4U.K.Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.

5U.K.Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.

6U.K.Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.

Yn ôl i’r brig

Options/Help

Print Options

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.

Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys

Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel deddfwyd fersiwn a ddefnyddiwyd am y copi print
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Llinell Amser Newidiadau

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel deddfwyd fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill